Dr Andrea Spezzi, CMO, R&D Head and co-founder of Orchard Therapeutics, has been named as one of the women changing the face and future of healthcare in the BioBeat 50 Movers and Shakers in the BioBusiness 2016 report. Released annually, the report celebrates 50 outstanding women entrepreneurs and business leaders who are recognised for their contributions to global health innovation.

BioBeat’s founder Miranda Weston-Smith explained,” the women in this report are transforming today’s challenges into tomorrow’s opportunities, they are magnetic in their creativity and openness to change. And with this, they are re-writing the boundaries and connections throughout the spectrum of life sciences and health.’

John Kearney, President of the Association of the British Pharmaceutical Industry added: ‘It is hugely encouraging to see ambitious and intellectually curious women determined to help keep the UK at the forefront of developing innovative medicines and treatments for patients. The advances in research, funding models, technology and drug development that these women are pursuing and delivering give a glimpse of what could be achieved’.

Andrea who is leading Orchard’s clinical aspects of partnerships with world-renowned experts commented on her nomination: “I am delighted to have been recognised alongside some outstanding peers and rising stars in the field. Our work at Orchard Therapeutics is helping shaping the future of medicine and transforming the lives of those suffering from rare and devastating diseases. We work passionately and tirelessly with an amazing group of experts and talented professionals to help patients in need and to advance science. I hope my nomination inspires others and particularly future generations of women entrepreneurs in science”